Skip to main content
NCBI home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1988 Jan;81(1):32–38. doi: 10.1172/JCI113306

Phorbol ester restores L-system amino acid transport of B lymphocytes in chronic lymphocytic leukemia.

T J Woodlock 1, G B Segel 1, M A Lichtman 1
PMCID: PMC442469  PMID: 3257220

Abstract

L (leucine-favoring)-system amino acid transport is uniquely and selectively diminished in chronic lymphocytic leukemia B lymphocytes: the maximal velocity of transport is 10% of normal B lymphocytes. We examined L-system transport in chronic leukemic B lymphocytes after incubation with tetradecanoyl phorbol acetate to determine if the transport abnormality can be corrected by the apparent cell maturation induced by this agent. Amino acid uptake was measured using 2-amino-2-carboxy-bicycloheptane, an L-system specific synthetic amino acid. Marked enhancement of L-system transport occurred in each of 12 leukemic cell populations; the initial velocity of transport in phorbol ester-treated cells increased 8-fold and 14-fold at 16 and 40 h, respectively, compared with untreated cells. The Vmax of the L-system in phorbol ester-treated leukemic cells was similar to that of phorbol ester-treated normal B lymphocytes. The L-system enhancement of the leukemic cells paralleled the development of plasmacytoid features at 40 h. Uptake of leucine, a naturally occurring L-system amino acid, was also increased by tetradecanoyl phorbol acetate. Cycloheximide, 100 micrograms/ml, which inhibited over 90% of protein synthesis in phorbol ester-treated chronic leukemic cells, blocked completely the phorbol ester-induced L-system enhancement. Phorbol ester treatment restores the selective L-system transport defect in chronic lymphocytic leukemia B lymphocytes, and this process coincides with in vitro maturation of the leukemic cells.

Full text

PDF
32

Images in this article

35Image
on p.35
35Image
on p.35

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Antin J. H., Emerson S. G., Martin P., Gadol N., Ault K. A. Leu-1+ (CD5+) B cells. A major lymphoid subpopulation in human fetal spleen: phenotypic and functional studies. J Immunol. 1986 Jan;136(2):505–510. [PubMed] [Google Scholar]
  2. Ashendel C. L. The phorbol ester receptor: a phospholipid-regulated protein kinase. Biochim Biophys Acta. 1985 Sep 9;822(2):219–242. doi: 10.1016/0304-4157(85)90009-7. [DOI] [PubMed] [Google Scholar]
  3. Caligaris-Cappio F., Gobbi M., Bofill M., Janossy G. Infrequent normal B lymphocytes express features of B-chronic lymphocytic leukemia. J Exp Med. 1982 Feb 1;155(2):623–628. doi: 10.1084/jem.155.2.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Christensen H. N., Handlogten M. E., Lam I., Tager H. S., Zand R. A bicyclic amino acid to improve discriminations among transport systems. J Biol Chem. 1969 Mar 25;244(6):1510–1520. [PubMed] [Google Scholar]
  5. Collins S. J., Ruscetti F. W., Gallagher R. E., Gallo R. C. Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds. Proc Natl Acad Sci U S A. 1978 May;75(5):2458–2462. doi: 10.1073/pnas.75.5.2458. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Costa-Casnellie M. R., Segel G. B., Lichtman M. A. Signal transduction in human monocytes: relationship between superoxide production and the level of kinase C in the membrane. J Cell Physiol. 1986 Dec;129(3):336–342. doi: 10.1002/jcp.1041290311. [DOI] [PubMed] [Google Scholar]
  7. Frengley P. A., Lichtman M. A., Peck W. A. Adaptive enhancement of amino acid transport in human leukemia leukocytes: studies with alpha-aminoisobutyric acid. J Lab Clin Med. 1975 Dec;86(6):984–986. [PubMed] [Google Scholar]
  8. Gale R. P., Foon K. A. Chronic lymphocytic leukemia. Recent advances in biology and treatment. Ann Intern Med. 1985 Jul;103(1):101–120. doi: 10.7326/0003-4819-103-1-101. [DOI] [PubMed] [Google Scholar]
  9. Gordon J., Mellstedt H., Aman P., Biberfeld P., Klein G. Phenotypic modulation of chronic lymphocytic leukemia cells by phorbol ester: induction of IgM secretion and changes in the expression of B cell-associated surface antigens. J Immunol. 1984 Jan;132(1):541–547. [PubMed] [Google Scholar]
  10. Guidotti G. G., Borghetti A. F., Gazzola G. C. The regulation of amino acid transport in animal cells. Biochim Biophys Acta. 1978 Dec 15;515(4):329–366. doi: 10.1016/0304-4157(78)90009-6. [DOI] [PubMed] [Google Scholar]
  11. Handwerger B. S., Schwartz R. H. Separation of murine lymphoid cells using nylon wool columns. Recovery of the B cell-enriched population. Transplantation. 1974 Dec;18(6):544–548. doi: 10.1097/00007890-197412000-00013. [DOI] [PubMed] [Google Scholar]
  12. Kaibuchi K., Takai Y., Nishizuka Y. Protein kinase C and calcium ion in mitogenic response of macrophage-depleted human peripheral lymphocytes. J Biol Chem. 1985 Feb 10;260(3):1366–1369. [PubMed] [Google Scholar]
  13. Kensler T. W., Wertz P. W., Mueller G. C. Inhibition of phorbol ester-accelerated amino acid transport in bovine lymphocytes. Biochim Biophys Acta. 1979 Jun 1;585(1):43–52. doi: 10.1016/0304-4165(79)90323-4. [DOI] [PubMed] [Google Scholar]
  14. Klip A., Mack E., Cragoe E. J., Jr, Grinstein S. Regulation of amino acid uptake by phorbol esters and hypertonic solutions in rat thymocytes. J Cell Physiol. 1986 May;127(2):244–252. doi: 10.1002/jcp.1041270209. [DOI] [PubMed] [Google Scholar]
  15. LaMantia K., Conklyn M., Quagliata F., Silber R. Lymphocyte 5'-nucleotidase: absence of detectable protein in chronic lymphocytic leukemia. Blood. 1977 Oct;50(4):683–689. [PubMed] [Google Scholar]
  16. Mastro A. M. Phorbol ester tumor promoters and lymphocyte proliferation. Cell Biol Int Rep. 1983 Nov;7(11):881–893. doi: 10.1016/0309-1651(83)90206-0. [DOI] [PubMed] [Google Scholar]
  17. Okamura J., Letarte M., Stein L. D., Sigal N. H., Gelfand E. W. Modulation of chronic lymphocytic leukemia cells by phorbol ester: increase in Ia expression, IgM secretion and MLR stimulatory capacity. J Immunol. 1982 May;128(5):2276–2280. [PubMed] [Google Scholar]
  18. Parks D. R., Bryan V. M., Oi V. T., Herzenberg L. A. Antigen-specific identification and cloning of hybridomas with a fluorescence-activated cell sorter. Proc Natl Acad Sci U S A. 1979 Apr;76(4):1962–1966. doi: 10.1073/pnas.76.4.1962. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Rovera G., Santoli D., Damsky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci U S A. 1979 Jun;76(6):2779–2783. doi: 10.1073/pnas.76.6.2779. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Scully S. P., Segel G. B., Lichtman M. A. Plasma membrane vesicles prepared from unadhered monocytes: characterization of calcium transport and the calcium ATPase. Cell Calcium. 1982 Dec;3(6):515–530. doi: 10.1016/0143-4160(82)90042-2. [DOI] [PubMed] [Google Scholar]
  21. Segel G. B., Cokelet G. R., Lichtman M. A. The measurement of lymphocyte volume: importance of reference particle deformability and counting solution tonicity. Blood. 1981 May;57(5):894–899. [PubMed] [Google Scholar]
  22. Segel G. B., Lichtman M. A. Amino acid transport in human lymphocytes: distinctions in the enhanced uptake with PHA treatment or amino acid deprivation. J Cell Physiol. 1981 Feb;106(2):303–308. doi: 10.1002/jcp.1041060217. [DOI] [PubMed] [Google Scholar]
  23. Segel G. B., Lichtman M. A. Decreased L-system for amino acid transport in chronic lymphocytic leukemic lymphocytes. J Biol Chem. 1982 Aug 25;257(16):9255–9257. [PubMed] [Google Scholar]
  24. Segel G. B., Lichtman M. A., Gordon B. R., MacPherson J. L., Nusbacher J. Plateletpheresis residues: a source of large quantities of human blood lymphocytes. Transfusion. 1976 Sep-Oct;16(5):455–459. doi: 10.1046/j.1537-2995.1976.16577039302.x. [DOI] [PubMed] [Google Scholar]
  25. Segel G. B., Ryan D. H., Lichtman M. A. Ecto-nucleotide triphosphatase activity of human lymphocytes: studies of normal and CLL lymphocytes. J Cell Physiol. 1985 Sep;124(3):424–432. doi: 10.1002/jcp.1041240310. [DOI] [PubMed] [Google Scholar]
  26. Segel G. B., Simon W., Lichtman M. A. A multicomponent analysis of amino acid transport systems in human lymphocytes. 1. Kinetic parameters of the A and L systems and pathways of uptake of naturally occurring amino acids in blood lymphocytes. J Cell Physiol. 1983 Sep;116(3):372–378. doi: 10.1002/jcp.1041160315. [DOI] [PubMed] [Google Scholar]
  27. Segel G. B., Simon W., Lichtman M. A. Multicomponent analysis of amino acid transport in human lymphocytes. Diminished L-system transport in chronic leukemic B lymphocytes. J Clin Invest. 1984 Jul;74(1):17–24. doi: 10.1172/JCI111398. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tötterman T. H., Nilsson K., Sundström C. Phorbol ester-induced differentiation of chronic lymphocytic leukaemia cells. Nature. 1980 Nov 13;288(5787):176–178. doi: 10.1038/288176a0. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES